[Pharmacological and clinical effects of cholinesterase antagonist hexamethylene-bis(N-methylcarbaminoyl-1-methyl-3-oxypyridiniumbromide); (BC 51)].
D002800:Cholinesterase Inhibitors; D003510:Cyclohexanes; D006801:Humans; D009388:Neostigmine / Q000031:analogs & derivatives
D002800:Cholinesterase Inhibitors; D003510:Cyclohexanes; D009388:Neostigmine; C506365:Cyclohexane
CHOLINESTERASE/antagonists; NEOSTIGMINE/related compounds
Pharmakologische und klinische Wirkungen des Cholinesterasehemmkörpers Hexamethylen-bis(N-methyl-carbaminoly-1-methyl-3-oxypyridiniumbromid) BC 51).